Convalescent plasma treatment in pediatrics, secured by the THERAFLEX MB-Plasma system for Pathogen Reduction, once again, showed its efficacy to fight againt Covid19

Published on 2 years ago

Convalescent plasma treatment in pediatrics, secured by the THERAFLEX MB-Plasma system for Pathogen Reduction, once again, showed its efficacy to fight againt Covid19.

Download this document

SHARE THIS POST

Other press releases

20th March 2023

Eurasanté 2030: Macopharma supports Lille Biocluster application

6th December 2022

Macopharma presented in Capital

7th October 2022

Macopharma : More than 45 years of expertise in blood process innovative solutions

15th October 2020

Convalescent plasma treatment in pediatrics, secured by the THERAFLEX MB-Plasma system for Pathogen Reduction, once again, showed its efficacy to fight againt Covid19

Other press releases

Eurasanté 2030: Macopharma supports Lille Biocluster application

Macopharma presented in Capital

Macopharma : More than 45 years of expertise in blood process innovative solutions

The first application of convalescentplasma using the THERAFLEXMBPLASMA technology from Macopharma, in Germany